PQVault is a product of QuantiCor Security Visit QuantiCor Security LinkedIn
Use case3 min read

Sharing study data securely: pharma and medtech working with CROs

Protocols, interim analyses and regulatory documents move between many parties. How they stay confidential and traceable.

Redaktion QuantiCor SecurityQuantiCor Security GmbH · Darmstadt
Studiendaten sicher teilen: Pharma und Medtech im Austausch mit CROs
Key takeaways
  • In clinical programmes, sponsor, CRO, trial sites and reviewers constantly exchange confidential documents.
  • A data room with roles, a confidentiality agreement before opening and an audit log replaces mailing lists and open cloud folders.
  • Research data stays valuable for years, so post-quantum protection belongs in the selection criteria.

A mid-sized medtech manufacturer is preparing a clinical investigation. The protocol goes to a CRO in the Netherlands, biostatistics sits with a service provider in Poland, two university hospitals review the protocol, and a consultant handles the documents for the authority. Five organisations, several time zones, a dozen versions. Anyone who wants to share study data securely needs more than a shared folder.

What is at stake in clinical programmes

Study documents are doubly sensitive. They contain trade secrets — mechanisms of action, interim results and development plans whose disclosure affects share prices, partnerships and licensing negotiations. And they contain personal health data of participants, even when pseudonymised. The European Clinical Trials Regulation (EU) No 536/2014 and the GDPR require careful handling.

In practice the exchange often looks different: mailing lists with changing recipients, links to cloud folders without expiry, ZIP files with the password in the same e-mail thread. Who saw which version in the end can hardly be said.

Sharing study data securely: data room instead of mailing list

A data room brings all documents of a programme together in one place, with clear roles:

  • Sponsor maintains structure and approvals.
  • CRO and service providers see the areas they need for their work and upload their results.
  • Trial sites and reviewers receive only the documents they are to review, view-only if desired, with watermarks and without download.

What matters is that permissions have a validity period. When a contract with a service provider ends, so does its access — without anyone having to adjust folder rights by hand.

Confidentiality before the first click

In early phases, such as the search for trial sites or licensing partners, documents go to organisations with which there is no contract yet. The usual practice is a confidentiality agreement sent back and forth as a PDF, signed, scanned and filed.

It is simpler when the agreement comes directly before opening: the recipient reads the text, accepts it with their name, and only then does the document open. The acceptance is recorded with the full text, version and time and signed by the platform. The sponsor sees in the overview who has agreed. For documents whose receipt must be provable, such as protocol versions, an acknowledgement of receipt with signature is added.

Rule of thumb: Sending is not the risk — everything afterwards is: copies, forwarding, forgotten permissions. Good tools make the afterwards visible and controllable.

Long timelines, long confidentiality

From the preclinical phase to approval often takes many years, and data from completed studies remains relevant for later indications, patent proceedings and authority requests. Data transmitted encrypted today should therefore still be protected when much more powerful computers become available. That is why authorities such as the BSI and the European Commission now advise migrating to post-quantum cryptography. We summarised the timeline in the article on the EU roadmap for post-quantum cryptography.

What you can do now

  1. Map the exchange routes of a programme: who sends which documents to whom, via which channel?
  2. Define areas and roles: which partners need which part, for how long, with which right (view, download, upload)?
  3. Store the confidentiality agreement as a template: have it reviewed legally once, then use it for all early contacts.
  4. Involve external partners early: access without installation lowers the hurdle for CROs and hospitals.
  5. Check the encryption: end-to-end and with NIST-standardised post-quantum algorithms, stored in the EU.

PQVault for study programmes

PQVault Spaces offers data rooms with roles, approvals, signatures and audit logs for sponsor, CRO and partners. Individual documents for external recipients go via PQVault Store & Share as links with rules, with a confidentiality agreement before opening and acknowledgement of receipt if desired. All content is end-to-end encrypted, additionally with NIST-standardised post-quantum algorithms. More industry scenarios under Pharma & medtech.

PQVault is a product of QuantiCor Security GmbH, Darmstadt — specialists in post-quantum cryptography. More about QuantiCor Security

Three solutions for this topic

PQVault

Ready for data that stays confidential tomorrow?

Ready to go as SaaS, hosted in the EU. NIST-standardised post-quantum methods in every module.